Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Goodwill & Intangibles (2016 - 2025)

Sanofi's Goodwill & Intangibles history spans 6 years, with the latest figure at $22.1 billion for Q4 2022.

  • For Q4 2022, Goodwill & Intangibles fell 9.84% year-over-year to $22.1 billion; the TTM value through Dec 2022 reached $22.1 billion, down 9.84%, while the annual FY2022 figure was $22.8 billion, 9.97% down from the prior year.
  • Goodwill & Intangibles for Q4 2022 was $22.1 billion at Sanofi, down from $24.5 billion in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $75.5 billion in Q4 2018 and bottomed at $1.1 billion in Q3 2018.
  • The 4-year median for Goodwill & Intangibles is $24.5 billion (2021), against an average of $35.2 billion.
  • The largest annual shift saw Goodwill & Intangibles increased 20.16% in 2018 before it tumbled 53.7% in 2021.
  • A 4-year view of Goodwill & Intangibles shows it stood at $75.5 billion in 2018, then fell by 29.92% to $52.9 billion in 2020, then crashed by 53.7% to $24.5 billion in 2021, then dropped by 9.84% to $22.1 billion in 2022.
  • Per Business Quant, the three most recent readings for SNY's Goodwill & Intangibles are $22.1 billion (Q4 2022), $24.5 billion (Q4 2021), and $52.9 billion (Q4 2020).